date:Mar 14, 2013
115 million. This included the 45 million acquisition of Aseptic Solutions in the USA to enhance Global Nutritionals Ingredient Technologies; the opening of a Customised Premix Solutions plant in Europe; capacity expansion in Performance Nutrition and a new cheese innovation centre in Idaho.
Glanbias Ingredient Technologies business markets a range of dairy and whey based ingredients, from whey protein concentrate 34 (WPC34) and lactose to whey protein concentrate 80 (WPC80) and whey protein i